Pharmacokinetics of clomipramine and desmethylclomipramine after single-dose intravenous and oral administrations in cats.

A cross-over study was performed in six adult spayed cats to determine the pharmacokinetics of clomipramine and its metabolite, desmethylclomipramine (DCMP) after intravenous (0.25 mg/kg) and oral (0.5 mg/kg) single-dose administrations. Plasma clomipramine and DCMP were measured by high-performance liquid chromatography at regular intervals for up to 30 h. Intravenous clomipramine best fit a two-compartmental model yielding an elimination rate constant of 0.037-0.09 h(-1) from which a mean half-life of 12.3 h was calculated. Mean clomipramine AUC(0--infinity) (ngxh/mL), clearance (L/hxkg), V(ss) (L/kg) and MRT (h) values were 652.5, 0.393, 5.0, and 13.5, respectively. Compartmental modeling for clomipramine, after oral administration, and DCMP after both administrations, produced wide parameter estimates and plots of residuals indicated poor goodness of fit. Noncompartmental analysis yielded mean AUC(0--30 h) (ngxh/mL), C(max) (ng/mL) and T(max) (h) of 948.3, 87.5 and 6.2 for clomipramine, and 613.8, 34.8, and 12.8 for DCMP respectively after oral administration. Clomipramine bioavailability was 90%. The present study showed marked pharmacokinetic variability for clomipramine and DCMP through biphasic absorption and potential genetic variability in clomipramine metabolism. It was concluded that population pharmacokinetics would allow better characterization of clomipramine variability that may explain the variability in clinical response noted in cats.

[1]  W. Seewald,et al.  Determination of the dosage of clomipramine for the treatment of urine spraying in cats. , 2004, Journal of the American Veterinary Medical Association.

[2]  Matthias J. Müller,et al.  Impact of polymorphisms of cytochrome-P450 isoenzymes 2C9, 2C19 and 2D6 on plasma concentrations and clinical effects of antidepressants in a naturalistic clinical setting , 2004, European Journal of Clinical Pharmacology.

[3]  B. Hart,et al.  Effects of a selective serotonin reuptake inhibitor on urine spraying behavior in cats. , 2001, Journal of the American Veterinary Medical Association.

[4]  K. Seksel,et al.  Use of clomipramine in treatment of obsessive-compulsive disorder, separation anxiety and noise phobia in dogs: a preliminary, clinical study. , 2001, Australian veterinary journal.

[5]  H. Jung,et al.  Pharmacokinetics of a Sustained‐Release Dosage Form of Clomipramine , 2000, Journal of clinical pharmacology.

[6]  L P Balant,et al.  Population Pharmacokinetics of Clomipramine, Desmethylclomipramine, and Hydroxylated Metabolites in Patients With Depression Receiving Chronic Treatment: Model Evaluation , 2000, Therapeutic drug monitoring.

[7]  L. Dell’Osso,et al.  Simultaneous plasma level analysis of clomipramine, N-desmethylclomipramine, and fluvoxamine by reversed-phase liquid chromatography. , 2000, Therapeutic drug monitoring.

[8]  Jacqueline C. Neilson,et al.  Effects of clomipramine hydrochloride on dominance-related aggression in dogs. , 1999, Journal of the American Veterinary Medical Association.

[9]  J. Serpell,et al.  Evaluation of clomipramine as an adjunct to behavioural therapy in the treatment of separation-related problems in dogs , 1999, Veterinary Record.

[10]  Lei Sun,et al.  A double-peak phenomenon in the pharmacokinetics of alprazolam after oral administration. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[11]  G. Martin,et al.  Evaluation of a polyurethane jugular catheter in cats placed using a modified Seldinger technique. , 1999, Australian veterinary journal.

[12]  A. Cribb,et al.  Clomipramine-induced urinary retention in a cat. , 1999, The Canadian veterinary journal = La revue veterinaire canadienne.

[13]  R. Ball,et al.  The pharmacokinetics of clomipramine and desmethylclomipramine in dogs: parameter estimates following a single oral dose and 28 consecutive daily oral doses of clomipramine. , 1998, Journal of veterinary pharmacology and therapeutics.

[14]  K. Seksel,et al.  Use of clomipramine in the treatment of anxiety-related and obsessive-compulsive disorders in cats. , 1998, Australian veterinary journal.

[15]  J. Dehasse.  Feline urine spraying , 1997 .

[16]  J. Oesterheld,et al.  Grapefruit juice and clomipramine: shifting metabolitic ratios. , 1997, Journal of clinical psychopharmacology.

[17]  P. Beaune,et al.  The biotransformation of clomipramine in vitro, identification of the cytochrome P450s responsible for the separate metabolic pathways. , 1996, The Journal of pharmacology and experimental therapeutics.

[18]  K. Shimoda,et al.  Clinical significance of plasma levels of clomipramine, its hydroxylated and desmethylated metabolites: prediction of clinical outcome in mood disorders using discriminant analysis of therapeutic drug monitoring data. , 1993, Journal of affective disorders.

[19]  L. Balant,et al.  Clomipramine Metabolism Model-Based Analysis of Variability Factors from Drug Monitoring Data , 1990, Clinical pharmacokinetics.

[20]  G. Jungkunz,et al.  Nonlinear pharmacokinetics of chlorimipramine after infusion and oral administration in patients , 1986, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[21]  H. Westenberg,et al.  Pharmacokinetics of clomipramine in depressive patients , 1981, Psychiatry Research.

[22]  J. Faigle,et al.  The Metabolism and Pharmacokinetics of Clomipramine (Anafranil) , 1973 .

[23]  G. Landsberg,et al.  Effects of clomipramine on cats presented for urine marking. , 2005, Journal of the American Animal Hospital Association.

[24]  S. Vandel,et al.  Biotransformation of amitriptyline in depressive patients: Urinary excretion of seven metabolites , 2004, European Journal of Clinical Pharmacology.

[25]  Brian Tomlinson,et al.  A Modified Two-Portion Absorption Model to Describe Double-Peak Absorption Profiles of Ranitidine , 2003, Clinical pharmacokinetics.

[26]  A. Litster.  Use of Clomipramine for treatment of behavioural disorders in 14 cats - Efficacy and side-effects , 2000 .

[27]  G. Strehlau,et al.  Pharmacokinetics of clomipramine in dogs following single-dose and repeated-dose oral administration. , 2000, American journal of veterinary research.

[28]  R. Hotz,et al.  Pharmacokinetics of clomipramine in dogs following single-dose intravenous and oral administration. , 2000, American journal of veterinary research.